Roguska J, Zubkiewicz-Kucharska A. Chemerin as an early marker of metabolic syndrome. Pediatric Endocrinology Diabetes and Metabolism. 2018;24(1):45-51.
APA
Roguska, J., & Zubkiewicz-Kucharska, A. (2018). Chemerin as an early marker of metabolic syndrome. Pediatric Endocrinology Diabetes and Metabolism, 24(1), 45-51.
Chicago
Roguska, Joanna, and Agnieszka Zubkiewicz-Kucharska. 2018. "Chemerin as an early marker of metabolic syndrome". Pediatric Endocrinology Diabetes and Metabolism 24 (1): 45-51.
Harvard
Roguska, J., and Zubkiewicz-Kucharska, A. (2018). Chemerin as an early marker of metabolic syndrome. Pediatric Endocrinology Diabetes and Metabolism, 24(1), pp.45-51.
MLA
Roguska, Joanna et al. "Chemerin as an early marker of metabolic syndrome." Pediatric Endocrinology Diabetes and Metabolism, vol. 24, no. 1, 2018, pp. 45-51.
Vancouver
Roguska J, Zubkiewicz-Kucharska A. Chemerin as an early marker of metabolic syndrome. Pediatric Endocrinology Diabetes and Metabolism. 2018;24(1):45-51.
Chemerin (CHEM) is a protein synthesized primarily by adiposse tissue and liver. CHEM acts both paracrine and autocrine, stimulating adipocytes maturation and differentiation. In addition to its hormonal function, CHEM acts as a chemoattractant for immune cells, regulating the innate and acquired inflammatory response. Its pleiotropic properties also affect the carbohydrates and lipids metabolism. High concentrations of CHEM are observed in people with obesity, type 2 diabetes, hypertension, and hyperlipidemia – components of the metabolic syndrome. Therefore CHEM also may be considered as an early predictive marker for diagnosing metabolic syndrome, also in adolescence and childhood.
